SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-270067
Filing Date
2019-10-18
Accepted
2019-10-18 16:14:02
Documents
4
Period of Report
2019-10-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d808074d8k.htm 8-K 20231
2 EX-1.1 d808074dex11.htm EX-1.1 199788
3 EX-5.1 d808074dex51.htm EX-5.1 8524
4 GRAPHIC g808074g1018031415597.jpg GRAPHIC 2533
  Complete submission text file 0001193125-19-270067.txt   233332
Mailing Address 400 EAST JAMIE COURT, SUITE 302 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT, SUITE 302 SOUTH SAN FRANCISCO CA 94080 (650) 416-7700
Principia Biopharma Inc. (Filer) CIK: 0001510487 (see all company filings)

IRS No.: 263487603 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38653 | Film No.: 191157886
SIC: 2834 Pharmaceutical Preparations